{"id":"https://openalex.org/W2284501784","doi":"https://doi.org/10.1007/978-1-4613-1573-5_21","title":"Anti-tumor Effects of Monoclonal Antibody-ricin Conjugates In Vitro and In Vivo","display_name":"Anti-tumor Effects of Monoclonal Antibody-ricin Conjugates In Vitro and In Vivo","publication_year":1988,"publication_date":"1988-01-01","ids":{"openalex":"https://openalex.org/W2284501784","doi":"https://doi.org/10.1007/978-1-4613-1573-5_21","mag":"2284501784"},"language":"en","primary_location":{"id":"doi:10.1007/978-1-4613-1573-5_21","doi":"https://doi.org/10.1007/978-1-4613-1573-5_21","is_oa":false,"landing_page_url":"https://doi.org/10.1007/978-1-4613-1573-5_21","pdf_url":null,"source":{"id":"https://openalex.org/S4306463937","display_name":"Springer eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Applications of Monoclonal Antibodies","raw_type":"book-chapter"},"volume":{"id":"https://openalex.org/W3144962956","display_name":"Clinical Applications of Monoclonal Antibodies"},"type":"book-chapter","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108761410","display_name":"David C. Blakey","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David C. Blakey","raw_affiliation_strings":["Drug Targeting Laboratory, Imperial Cancer Research Fund, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Targeting Laboratory, Imperial Cancer Research Fund, London, UK","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111984641","display_name":"Philip E. Thorpe","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Philip E. Thorpe","raw_affiliation_strings":["Drug Targeting Laboratory, Imperial Cancer Research Fund, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Targeting Laboratory, Imperial Cancer Research Fund, London, UK","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.28762542,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"233","last_page":"243"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12477","display_name":"Toxin Mechanisms and Immunotoxins","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12477","display_name":"Toxin Mechanisms and Immunotoxins","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immunotoxins","display_name":"immunotoxins","score":0.9850000143051147},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.8569999933242798},{"id":"https://openalex.org/keywords/ricin","display_name":"ricin","score":0.9470000267028809},{"id":"https://openalex.org/keywords/tumor-associated-antigens","display_name":"tumor-associated antigens","score":0.8180000185966492},{"id":"https://openalex.org/keywords/targeted-cancer-therapy","display_name":"targeted cancer therapy","score":0.6629999876022339},{"id":"https://openalex.org/keywords/antibody-toxin-conjugates","display_name":"antibody-toxin conjugates","score":0.7020000219345093},{"id":"https://openalex.org/keywords/plant-toxins","display_name":"plant toxins","score":0.460999995470047},{"id":"https://openalex.org/keywords/diphtheria-toxin","display_name":"diphtheria toxin","score":0.8460000157356262},{"id":"https://openalex.org/keywords/pseudomonas-exotoxin-a","display_name":"Pseudomonas exotoxin A","score":0.8939999938011169},{"id":"https://openalex.org/keywords/abrin","display_name":"abrin","score":0.7440000176429749},{"id":"https://openalex.org/keywords/gelonin","display_name":"gelonin","score":0.9679999947547913},{"id":"https://openalex.org/keywords/tumor-cell-killing","display_name":"tumor cell killing","score":0.5450000166893005}],"concepts":[{"id":"https://openalex.org/C115085202","wikidata":"https://www.wikidata.org/wiki/Q425665","display_name":"Immunotoxin","level":4,"score":0.955710768699646},{"id":"https://openalex.org/C2777200438","wikidata":"https://www.wikidata.org/wiki/Q408668","display_name":"Ricin","level":3,"score":0.8210801482200623},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.7269110679626465},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6254968643188477},{"id":"https://openalex.org/C182179738","wikidata":"https://www.wikidata.org/wiki/Q907386","display_name":"Pseudomonas exotoxin","level":4,"score":0.6168122887611389},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.5928544402122498},{"id":"https://openalex.org/C33057221","wikidata":"https://www.wikidata.org/wiki/Q421580","display_name":"Diphtheria toxin","level":3,"score":0.5728891491889954},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5652443766593933},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.4782899022102356},{"id":"https://openalex.org/C956191","wikidata":"https://www.wikidata.org/wiki/Q930144","display_name":"Polyclonal antibodies","level":3,"score":0.46925947070121765},{"id":"https://openalex.org/C57992300","wikidata":"https://www.wikidata.org/wiki/Q2066956","display_name":"Potency","level":3,"score":0.43653008341789246},{"id":"https://openalex.org/C2778723905","wikidata":"https://www.wikidata.org/wiki/Q408649","display_name":"Exotoxin","level":3,"score":0.43181371688842773},{"id":"https://openalex.org/C2777367657","wikidata":"https://www.wikidata.org/wiki/Q184651","display_name":"Toxin","level":2,"score":0.4229668378829956},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.4023772180080414},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4008943438529968},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.393105149269104},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.3005639314651489},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.23191478848457336},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.19177886843681335},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1007/978-1-4613-1573-5_21","doi":"https://doi.org/10.1007/978-1-4613-1573-5_21","is_oa":false,"landing_page_url":"https://doi.org/10.1007/978-1-4613-1573-5_21","pdf_url":null,"source":{"id":"https://openalex.org/S4306463937","display_name":"Springer eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Applications of Monoclonal Antibodies","raw_type":"book-chapter"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8560000061988831,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Zero hunger","score":0.4099999964237213,"id":"https://metadata.un.org/sdg/2"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W162818717","https://openalex.org/W389377414","https://openalex.org/W645218116","https://openalex.org/W1483668606","https://openalex.org/W1500247723","https://openalex.org/W1528681389","https://openalex.org/W1573682211","https://openalex.org/W1604700329","https://openalex.org/W1893863133","https://openalex.org/W1973835842","https://openalex.org/W1988428921","https://openalex.org/W1994291236","https://openalex.org/W1994570341","https://openalex.org/W2019530646","https://openalex.org/W2032629482","https://openalex.org/W2043120873","https://openalex.org/W2045096143","https://openalex.org/W2053153019","https://openalex.org/W2104670043","https://openalex.org/W2120705932","https://openalex.org/W2149866422","https://openalex.org/W2166129740","https://openalex.org/W2461241799","https://openalex.org/W2606631616","https://openalex.org/W2608646275","https://openalex.org/W2883198529","https://openalex.org/W4233995996","https://openalex.org/W6602085043"],"related_works":["https://openalex.org/W249297464","https://openalex.org/W3021060847","https://openalex.org/W1978689462","https://openalex.org/W1993885156","https://openalex.org/W2066594847","https://openalex.org/W2467276012","https://openalex.org/W1548465046","https://openalex.org/W187069666","https://openalex.org/W2050099452","https://openalex.org/W2001727492"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-10T09:11:00.788812","created_date":"2016-06-24T00:00:00"}